Summary
Aarti Pharmalabs shares hit the 20% upper circuit after the company reported a 65.4% year-on-year surge in Q1 FY27 net profit to Rs 76.14 crore. Revenue also increased by 38.7% to Rs 535.79 crore, and the company approved a Rs 149-crore capital expenditure plan for manufacturing capacity expansion.